Genetic testing company 23andMe is preparing for a renewed auction of its assets after a federal judge agreed to reopen the ...

A class action lawsuit, resignations, and layoffs plagued 23andMe, which filed for Chapter 11 in March. Biotech company Regeneron is buying the DNA testing startup's assets for $256 million.

Civil liberties advocates say the Trump administration's data collection and sharing endanger Americans' constitutional rights.

Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.

Comprehensive coverage of local, regional, state and national news events that affect the Tampa area are provided by the News Channel 8 First at 4:00 News team.